Skip to main content
. 2021 Jan 1;34(1):19–26. doi: 10.3344/kjp.2021.34.1.19

Fig. 2.

Fig. 2

3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay after treating 0.01% and 0.05% of lidocaine (A), dextrose (B), and 0.01% of lidocaine (L0.01) and 1% of dextrose (D1) and combination treatment of L0.01 + D1 (C) for 24 hours. Medians and standard deviation, n = 8 for each group. Ctrl: control. ***P < 0.001.